| 45.95 Data as of May 10 |  +0.46 / +1.01%Today’s Change | 37.02 Today|||52-Week Range 48.79 | +12.24% Year-to-Date |
| Simcere Beats 1Q Earnings & Revenue Estimate - Analyst Blog May 10 / Zacks.com | Merck's Liptruzet Approved in the US - Analyst Blog May 07 / Zacks.com |
| What's Missing in This Market May 10 / TheStreet.com | Wider-than-Expected Loss at Endocyte - Analyst Blog May 06 / Zacks.com |
| Merck & Co Inc (MRK): Today's Featured Drugs Winner May 09 / TheStreet.com | Company News for May 2, 2013 - Corporate Summary May 02 / Zacks.com |
| GSK and Merck pioneer vaccine deal May 09 / FT.com | Merck Misses on Revenues but Beats on EPS May 01 / MotleyFool.com |
| 5 Stocks Advancing The Drugs Industry May 07 / TheStreet.com | Stocks Market News for May 1, 2013 - Market News May 01 / Zacks.com |
| Previous close | 45.49 |
| Today’s open | 45.54 |
| Day’s range | 45.49 - 45.95 |
| Volume | 13,888,485 |
| Average volume (3 months) | 16,241,436 |
| Market cap | $137.3B |
| Dividend yield | 3.74% |
| Earnings growth (last year) | -0.99% |
| Earnings growth (this year) | -7.07% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | -1.63% |
| P/E ratio | 23.6 |
| Price/Sales | 2.63 |
| Price/Book | 2.60 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi SA | +0.66 | +1.22% |
| GSKGlaxoSmithKline PLC | +0.92 | +1.81% |
| NVSNovartis AG | +0.72 | +0.97% |
| NVONovo Nordisk A/S | -0.26 | -0.15% |
| Next reporting date | July 22, 2013 |
| EPS forecast (this quarter) | $0.86 |
| Annual revenue (last year) | $47.3B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 13.02% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer Kenneth C. Frazier |
Chief Financial Officer & Executive Vice President Peter N. Kellogg, MBA |
Corporate headquarters Whitehouse Station, New Jersey |
.
